23andMe to share customer gene data with GlaxoSmithKline for $300M

Re:23andMe to share customer gene data with GlaxoSmithKline ... by zepto on Tuesday December 17, 2019 @11:30PM (#21821815)

What value are you adding with this meaningless comment?

I was refuting the parent’s point:

“any change like that would be major national news, debated extensively in Congress, and then, if turned into a new law, would roll out over years.

Which is manifestly false for the reasons I outlined.

Are you suggesting otherwise?

[ Parent | on HN ]

Re:23andMe to share customer gene data with GlaxoSmithKline ... by dekhn on Wednesday December 18, 2019 @10:46AM (#21826000)

The problem is you gave a single anecdotal example, and there was a bunch of attention paid at the time anyway and lots of people complained.

You can't insert major changes to health laws in omnibus spending bills.

[ Parent | on HN ]

Re:23andMe to share customer gene data with GlaxoSmithKline ... by zepto on Wednesday December 18, 2019 @10:58AM (#21826146)

There is nothing anecdotal about it, since it is a fact.

Almost nobody complained, there was no meaningful mainstream coverage, and most people don’t even know there was a change even now.

And you don’t need to insert a major change to punch a hole in the law. A small exception will do it.

[ Parent | on HN ]